Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 2501717)

Published in Neurosci Lett on April 24, 1989

Authors

B L Anthony1, R L Dennison, R S Aronstam

Author Affiliations

1: Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta 30912.

Articles by these authors

Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol Pharmacol (1978) 1.33

Activation, inactivation, and desensitization of acetylcholine receptor channel complex detected by binding of perhydrohistrionicotoxin. Proc Natl Acad Sci U S A (1980) 1.28

Phencyclidine interactions with the ionic channel of the acetylcholine receptor and electrogenic membrane. Proc Natl Acad Sci U S A (1980) 1.11

Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotinic receptor. Mol Pharmacol (1980) 1.09

Selective blockade of NMDA-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett (1990) 1.07

The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J Pharmacol Exp Ther (1990) 1.03

M3 muscarinic acetylcholine receptors regulate cytoplasmic myosin by a process involving RhoA and requiring conventional protein kinase C isoforms. J Biol Chem (1999) 1.01

Electrophysiological and biochemical studies on enhancement of desensitization by phenothiazine neuroleptics. Proc Natl Acad Sci U S A (1983) 0.96

[3H]Phencyclidine: a probe for the ionic channel of the nicotinic receptor. Proc Natl Acad Sci U S A (1980) 0.94

Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter. Neurosci Lett (1990) 0.94

Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochem Pharmacol (1995) 0.92

Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors. Mol Pharmacol (1989) 0.91

Conversion between configurational states of the muscarinic receptor in rat brain. Eur J Pharmacol (1977) 0.91

The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties. Mol Pharmacol (1984) 0.90

Structural and stereochemical requirements for muscarinic receptor binding. Mol Pharmacol (1979) 0.90

Sites of action of phencyclidine. I. Effects on the electrical excitability and chemosensitive properties of the neuromuscular junction of skeletal muscle. Mol Pharmacol (1980) 0.90

Similarities in the binding sites of the muscarinic receptor and the ionic channel of the nicotinic receptor. Biochem Pharmacol (1980) 0.90

Sites of action of phencyclidine. III. Interactions with muscarinic receptors. Mol Pharmacol (1980) 0.89

Nature of regional and chemically-induced differences in the binding properties of muscarinic acetylcholine receptors from rat brain. Neuropharmacology (1980) 0.89

5,8-disubstituted indolizidines: a new class of noncompetitive blockers for nicotinic receptor-channels. Neurochem Res (1991) 0.89

Solubilization of muscarinic acetylcholine receptors of bovine brain. Life Sci (1978) 0.89

Clonidine protection from the toxicity of soman, an organophosphate acetylcholinesterase inhibitor, in the mouse. J Pharmacol Exp Ther (1986) 0.87

Interaction of gephyrotoxin and indolizidine alkaloids with the nicotinic acetylcholine receptor-ion channel complex of Torpedo electroplax. Neurochem Res (1986) 0.86

Cholinergic supersensitivity and decreased number of muscarinic receptors in atria from short-term diabetic rats. J Mol Cell Cardiol (1984) 0.85

Effects of adenosine and analogs on adenylate cyclase activity in cultured bovine aortic endothelial cells. Biochem Pharmacol (1990) 0.85

Ketamine inhibition of ligand binding to cholinergic receptors and ion channels. Eur J Pharmacol (1982) 0.84

Development of muscarinic cholinergic receptors in inbred strains of mice: identification of receptor heterogeneity and relation to audiogenic seizure susceptibility. Brain Res (1979) 0.84

Changes in cholinergic parameters associated with failure of conotruncal septation in embryonic chick hearts after neural crest ablation. Circ Res (1985) 0.84

Clonidine protection from soman and echothiophate toxicity in mice. Life Sci (1986) 0.84

Regulation of [3H]perhydrohistrionicotoxin binding to Torpedo ocellata electroplax by effectors of the acetylcholine receptor. J Biol Chem (1981) 0.84

Influence of N-ethylmaleimide on cholinoceptors and responses in longitudinal muscles from guinea-pig ileum. Br J Pharmacol (1982) 0.84

Muscarinic cholinergic binding in human erythrocyte membranes. Life Sci (1977) 0.84

Involvement of protein kinase C and protein kinase A in the muscarinic receptor signalling pathways mediating phospholipase C activation, arachidonic acid release and calcium mobilisation. Cell Signal (1999) 0.83

Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state. Neurochem Res (1986) 0.82

Anesthetic effects on muscarinic signal transduction. Int Anesthesiol Clin (1989) 0.82

Decahydroquinoline alkaloids: noncompetitive blockers for nicotinic acetylcholine receptor-channels in pheochromocytoma cells and Torpedo electroplax. Neurochem Res (1991) 0.82

Increased muscarinic responsiveness and decreased muscarinic receptor content in ileal smooth muscle in diabetes. J Pharmacol Exp Ther (1990) 0.82

Interactions of tricyclic antidepressants with a synaptic ion channel. Life Sci (1981) 0.81

Effect of colchicine and taxol on stimulation of G protein GTPase activity in anterior pituitary lobe of rats by gonadotrophin- and thyrotrophin-releasing hormones. J Reprod Fertil (1993) 0.81

Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies. Mol Pharmacol (1984) 0.80

Interactions of microtubule-active agents with nicotinic acetylcholine receptors. Relationship to their inhibition of catecholamine secretion by adrenal chromaffin cells. Mol Pharmacol (1985) 0.80

Reversible conversion between affinity states for agonists of the muscarinic acetylcholine receptor from rat brain. Biochem Pharmacol (1979) 0.79

Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites. J Pharmacol Exp Ther (1991) 0.79

A novel agonist binding site on nicotinic acetylcholine receptors. J Recept Res (1993) 0.79

Altered muscarinic receptor properties and function in the heart in diabetes. J Pharmacol Exp Ther (1987) 0.79

Pyrazole, an alcohol dehydrogenase inhibitor, has dual effects on N-methyl-D-aspartate receptors of hippocampal pyramidal cells: agonist and noncompetitive antagonist. J Pharmacol Exp Ther (1992) 0.79

Precursors of cholinergic false transmitters: central effects on blood pressure and direct interactions with cholinergic receptors. Neuropharmacology (1988) 0.78

Benzomorphan interactions with acetylcholine receptor complexes from Torpedo. Eur J Pharmacol (1983) 0.78

Adrenergic agonists protect against soman, an irreversible acetylcholinesterase inhibitor. Toxicol Lett (1987) 0.78

Modulation of adenylate cyclase activity in cultured bovine pulmonary arterial endothelial cells. Effects of adenosine and derivatives. Biochem Pharmacol (1989) 0.77

Inhibition of M3 muscarinic acetylcholine receptor-mediated Ca2+ influx and intracellular Ca2+ mobilization in neuroblastoma cells by the Ca2+/calmodulin-dependent protein kinase inhibitor 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-trosyl]-4-phenylpiperazin e (KN-62). Biochem Pharmacol (1997) 0.77

Volatile anesthetics and NMDA receptors. Enflurane inhibition of glutamate-stimulated [3H]MK-801 binding and reversal by glycine. Neurosci Lett (1991) 0.77

Role of central biogenic amines on the protection afforded by clonidine against the toxicity of soman, an irreversible cholinesterase inhibitor. Toxicol Lett (1988) 0.77

Colchicine inhibits acetylcholine receptor stimulation of G protein GTPase activity in rat striatum. Pharmacol Toxicol (1991) 0.77

Characterization of the muscarinic receptor subtypes in the bovine corneal epithelial cells. J Ocul Pharmacol Ther (1996) 0.77

Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman. Neurotoxicol Teratol (1989) 0.77

Muscarinic acetylcholine receptors in chick heart: influence of heat and N-ethylmaleimide on receptor conformations and interactions with guanine nucleotide-dependent regulatory proteins. Neurosci Lett (1985) 0.77

Substance P receptor desensitization in the dorsal horn: possible involvement of receptor-G protein complexes. Brain Res (1993) 0.77

The influence of isoflurane on the synaptic activity of 5-hydroxytryptamine. Neurochem Res (1990) 0.77

Effects of halothane on high affinity agonist binding and guanine nucleotide sensitivity of muscarinic acetylcholine receptors from brainstem of rat. Neuropharmacology (1987) 0.77

Regulation of beta-adrenergic receptor density in the non-innervated and denervated embryonic chick heart. J Mol Cell Cardiol (1986) 0.77

Behavioral effects of toxic doses of soman, an organophosphate cholinesterase inhibitor, in the rat: protection afforded by clonidine. Pharmacol Biochem Behav (1988) 0.77

Retinoic acid-induced differentiation of a human neuroblastoma cell line alters muscarinic receptor expression. Brain Res Dev Brain Res (1993) 0.77

Fentanyl and sufentanil inhibit agonist binding to 5-HT1A receptors in membranes from the rat brain. Neuropharmacology (1991) 0.77

S-nitrosylation of m2 muscarinic receptor thiols disrupts receptor-G-protein coupling. Ann N Y Acad Sci (1995) 0.76

Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a. Mol Pharmacol (1986) 0.76

Effect of pH on muscarinic acetylcholine receptors from rat brainstem. J Neurochem (1986) 0.76

Influence of acute and chronic ethanol treatment on muscarinic responses and receptor expression in Chinese hamster ovary cells. Biochem Pharmacol (1997) 0.76

Anatoxin-a interactions with cholinergic synaptic molecules. Proc Natl Acad Sci U S A (1981) 0.75

Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers. Neurochem Res (1991) 0.75

Stimulation of the release of [32P]guanosine 5'-diphosphate from G proteins in the rat anterior pituitary lobe by gonadotrophin-releasing and thyrotrophin-releasing hormones. J Reprod Fertil (1992) 0.75

Guanine nucleotide sensitivity of muscarinic acetylcholine receptors from rat brainstem is eliminated by endogenous proteolytic activity. Neurosci Lett (1984) 0.75

Binding of [3H]perhydrohistrionicotoxin and [3H]phencyclidine to the nicotinic receptor-ion channel complex of Torpedo electroplax. Inhibition by histrionicotoxins and derivatives. Biochem Pharmacol (1985) 0.75

Molecular effects of dimethylanatoxin on the peripheral nicotinic acetylcholine receptor. J Pharmacol Exp Ther (1990) 0.75

Gonadotropin-releasing hormone and thyrotropin-releasing hormone regulation of g protein function in the rat anterior pituitary lobe. J Neuroendocrinol (1990) 0.75

Biphasic regulation of detergent-solubilized muscarinic acetylcholine receptors from rat cerebral cortex by N-ethylmaleimide. Res Commun Chem Pathol Pharmacol (1985) 0.75

Tricyclic antidepressant inhibition of depolarization-induced uptake of calcium by synaptosomes from rat brain. Biochem Pharmacol (1985) 0.75

Acetylcholine stimulates GTP binding to G proteins in rat striatum. Neuroreport (1991) 0.75

Effects of enflurane on 5-hydroxytryptamine transport in synaptosomes from rat brain. Biochem Pharmacol (1990) 0.75

High-affinity agonist binding to rat brainstem muscarinic receptors is eliminated by low pH. Neurosci Lett (1986) 0.75

Activation and blockade of the acetylcholine receptor-ion channel by the agonists (+)-anatoxin-a, the N-methyl derivative and the enantiomer. J Pharmacol Exp Ther (1990) 0.75

Halothane attenuation of muscarinic inhibition of adenylate cyclase in rat heart. Biochem Pharmacol (1988) 0.75

Influence of halothane on the interactions of serotonin1A and adenosine A1 receptors with G proteins in rat brain membranes. Biochem Pharmacol (1991) 0.75

Atropine-induced alterations of normal development of muscarinic receptors in the embryonic chick heart. J Mol Cell Cardiol (1983) 0.75

Protection by clonidine from the cardiovascular changes and lethality following soman administration in the rat: role of brain acetylcholine. Toxicol Appl Pharmacol (1988) 0.75

Influence of phospholipase C on muscarinic acetylcholine receptor binding in rat brain. Neurochem Res (1984) 0.75

Progesterone, testosterone and estradiol-17 beta inhibit gonadotropin-releasing hormone stimulation of G protein GTPase activity in plasma membranes from rat anterior pituitary lobe. Acta Endocrinol (Copenh) (1992) 0.75

Influence of anti-tubulin antibodies on muscarinic receptor modulation of G protein GTPase activity in rat striatum. Biochem Pharmacol (1990) 0.75

Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization. Mol Pharmacol (1984) 0.75

Interactions of chlordecone (kepone) and mirex with the nicotinic acetylcholine receptor--ion channel complex. Toxicol Lett (1986) 0.75

Influence of volatile anesthetics on muscarinic regulation of adenylate cyclase activity. Biochem Pharmacol (1990) 0.75

Effects of forskolin and analogues on nicotinic receptor-mediated sodium flux, voltage-dependent calcium flux, and voltage-dependent rubidium efflux in pheochromocytoma PC12 cells. Cell Mol Neurobiol (1990) 0.75

Influence of sulfhydryl reagents on potassium-stimulated calcium uptake by rat brain synaptosomes. Res Commun Chem Pathol Pharmacol (1984) 0.75

Selective antagonism by clonidine of the stereotyped and non-stereotyped motor activity elicited by atropine. Pharmacol Biochem Behav (1986) 0.75

Halothane effects on muscarinic acetylcholine receptor complexes in rat brain. Biochem Pharmacol (1986) 0.75

Test-tube equilibration of volatile anaesthetic concentrations. Br J Anaesth (1993) 0.75

Halothane disruption of alpha 2-adrenergic receptor-mediated inhibition of adenylate cyclase and receptor G-protein coupling in rat brain. Biochem Pharmacol (1990) 0.75

Clonidine prevents the short-term down regulation of muscarinic receptors in mouse brain induced by the acetylcholinesterase inhibitor soman. Neurosci Lett (1987) 0.75

Regional heterogeneity of muscarinic acetylcholine receptors from rat brain is retained after detergent solubilization. Neurosci Lett (1985) 0.75